A host defense peptide mimetic, brilacidin, potentiates caspofungin antifungal activity against human pathogenic fungi

By sjmartinez • April 13, 2023

Dos Reis TF, de Castro PA, Bastos RW, Pinzan CF, Souza PFN, Ackloo S, Hossain MA, Drewry DH, Alkhazraji S, Ibrahim AS, Jo H, Lightfoot JD, Adams EM, Fuller KK, deGrado WF, Goldman GH. A host defense peptide mimetic, brilacidin, potentiates caspofungin antifungal activity against human pathogenic fungi. Nat Commun. 2023 Apr 12;14(1):2052. doi: 10.1038/s41467-023-37573-y. PMID: 37045836; PMCID: PMC10090755.

Tags: Harbor UCLA, Infectious Diseases, Publications

Observance of rare congenital anomaly: dual right coronary artery

Bishay R, Aldana-Bitar J, Budoff MJ. Observance of rare congenital anomaly: dual right coronary artery. Coron Artery Dis. 2024 Sep 12. doi: 10.1097/MCA.0000000000001423. Epub ahead[...]

Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial

Evering TH, Moser C, Jilg N, Ritz J, Wohl DA, Li JZ, Margolis D, Javan AC, Eron JJ, Currier JS, Daar ES, Smith DM, Hughes[...]

Safety, efficacy, and pharmacokinetics of oral testosterone undecanoate in males with hypogonadism

Miner M, Wang C, Kaminetsky J, Khera M, Goldstein I, Carson C 3rd, Chidambaram N, King S, Dobs A. Safety, efficacy, and pharmacokinetics of oral[...]